Cargando…

An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Clinical practice guidelines (CPGs) on the prevention, surveillance, diagnosis and management of HCC are essential to guide clinical practice. The objective of this study was to evaluate the reporting qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haiyang, Tao, Meng, Li, Ding, Han, Jing, Cheng, Cheng, Ma, Yanfang, Wu, Yingxi, Shelat, Vishal G., Tustumi, Francisco, Satapathy, Sanjaya K., Kang, Koo Jeong, Wang, Qiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267298/
https://www.ncbi.nlm.nih.gov/pubmed/34277804
http://dx.doi.org/10.21037/atm-21-2611
_version_ 1783720119463051264
author Chen, Haiyang
Tao, Meng
Li, Ding
Han, Jing
Cheng, Cheng
Ma, Yanfang
Wu, Yingxi
Shelat, Vishal G.
Tustumi, Francisco
Satapathy, Sanjaya K.
Kang, Koo Jeong
Wang, Qiming
author_facet Chen, Haiyang
Tao, Meng
Li, Ding
Han, Jing
Cheng, Cheng
Ma, Yanfang
Wu, Yingxi
Shelat, Vishal G.
Tustumi, Francisco
Satapathy, Sanjaya K.
Kang, Koo Jeong
Wang, Qiming
author_sort Chen, Haiyang
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Clinical practice guidelines (CPGs) on the prevention, surveillance, diagnosis and management of HCC are essential to guide clinical practice. The objective of this study was to evaluate the reporting quality of the most recent CPGs for HCC published worldwide. METHODS: We systematically searched literature databases and websites of guideline development organizations and medical associations to extract CPGs on HCC published between January 2018 and December 2020. We evaluated the reporting quality using the Reporting Items for practice Guidelines in Healthcare (RIGHT) statement. We assessed for each of the 35 RIGHT checklist items whether the guidelines reported the corresponding information. We calculated the mean (± standard error of the mean, SEM) percentages of the guidelines’ compliance with the items (reporting rate), both overall and for each of the seven domains of the RIGHT checklist. RESULTS: We identified 22 guidelines, of which three (14%) were written in Chinese and 19 (86%) in English. The mean ±SEM overall reporting rate in the twenty-two guidelines was 56%±4%. The reporting rates of the seven domains were the following: basic information 81%±3%, background 58%±6%, evidence 58%±6%, recommendations 59%±5%, review and quality assurance 34%±10%, funding and declaration and management of interests 39%±4%, and other information 23%±6%. CONCLUSIONS: The reporting quality of the recently published guidelines for HCC was suboptimal. While there is no doubt about the great value of the CPGs’ recommendations in clinical practice, the reporting in CPGs for HCC still needs improvement.
format Online
Article
Text
id pubmed-8267298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-82672982021-07-16 An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist Chen, Haiyang Tao, Meng Li, Ding Han, Jing Cheng, Cheng Ma, Yanfang Wu, Yingxi Shelat, Vishal G. Tustumi, Francisco Satapathy, Sanjaya K. Kang, Koo Jeong Wang, Qiming Ann Transl Med Original Article BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Clinical practice guidelines (CPGs) on the prevention, surveillance, diagnosis and management of HCC are essential to guide clinical practice. The objective of this study was to evaluate the reporting quality of the most recent CPGs for HCC published worldwide. METHODS: We systematically searched literature databases and websites of guideline development organizations and medical associations to extract CPGs on HCC published between January 2018 and December 2020. We evaluated the reporting quality using the Reporting Items for practice Guidelines in Healthcare (RIGHT) statement. We assessed for each of the 35 RIGHT checklist items whether the guidelines reported the corresponding information. We calculated the mean (± standard error of the mean, SEM) percentages of the guidelines’ compliance with the items (reporting rate), both overall and for each of the seven domains of the RIGHT checklist. RESULTS: We identified 22 guidelines, of which three (14%) were written in Chinese and 19 (86%) in English. The mean ±SEM overall reporting rate in the twenty-two guidelines was 56%±4%. The reporting rates of the seven domains were the following: basic information 81%±3%, background 58%±6%, evidence 58%±6%, recommendations 59%±5%, review and quality assurance 34%±10%, funding and declaration and management of interests 39%±4%, and other information 23%±6%. CONCLUSIONS: The reporting quality of the recently published guidelines for HCC was suboptimal. While there is no doubt about the great value of the CPGs’ recommendations in clinical practice, the reporting in CPGs for HCC still needs improvement. AME Publishing Company 2021-06 /pmc/articles/PMC8267298/ /pubmed/34277804 http://dx.doi.org/10.21037/atm-21-2611 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Chen, Haiyang
Tao, Meng
Li, Ding
Han, Jing
Cheng, Cheng
Ma, Yanfang
Wu, Yingxi
Shelat, Vishal G.
Tustumi, Francisco
Satapathy, Sanjaya K.
Kang, Koo Jeong
Wang, Qiming
An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title_full An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title_fullStr An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title_full_unstemmed An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title_short An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist
title_sort evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the right checklist
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267298/
https://www.ncbi.nlm.nih.gov/pubmed/34277804
http://dx.doi.org/10.21037/atm-21-2611
work_keys_str_mv AT chenhaiyang anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT taomeng anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT liding anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT hanjing anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT chengcheng anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT mayanfang anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT wuyingxi anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT shelatvishalg anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT tustumifrancisco anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT satapathysanjayak anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT kangkoojeong anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT wangqiming anevaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT chenhaiyang evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT taomeng evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT liding evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT hanjing evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT chengcheng evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT mayanfang evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT wuyingxi evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT shelatvishalg evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT tustumifrancisco evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT satapathysanjayak evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT kangkoojeong evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist
AT wangqiming evaluationofthereportingqualityinclinicalpracticeguidelinesforhepatocellularcarcinomausingtherightchecklist